BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9543185)

  • 1. Cytokines and autoimmune beta cell destruction in NOD mouse fetal pancreas isografts in cyclophosphamide-induced diabetes.
    Kovarik J; Faulkner-Jones BE; Koulmanda M; Mandel TE
    Autoimmunity; 1997; 26(4):245-52. PubMed ID: 9543185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines during rejection of foetal pig and foetal mouse pancreas grafts in nonobese diabetic mice.
    Kovarik J; Koulmanda M; Mandel TE
    Transpl Immunol; 1997 Dec; 5(4):307-14. PubMed ID: 9504153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
    Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.
    Rothe H; Ito Y; Kolb H
    J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley A; Mandel TE
    Diabetes; 1998 Sep; 47(9):1399-405. PubMed ID: 9726227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenografts.
    Mandel TE; Koulmanda M; Bacelj A
    Horm Metab Res Suppl; 1990; 25():166-73. PubMed ID: 2088961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-V beta 8 antibody therapy prevents disease recurrence in fetal pancreas isografts in spontaneously diabetic nonobese diabetic mice.
    Bacelj A; Mandel TE; Charlton B
    Transplant Proc; 1992 Feb; 24(1):220-1. PubMed ID: 1539255
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-label immunohistochemical study of interleukin-4-and interferon-gamma-expressing cells within the pancreas of the NOD mouse during disease acceleration with cyclophosphamide.
    Reddy S; Karanam M; Poole CA; Ross JM
    Autoimmunity; 2000 Oct; 32(3):181-92. PubMed ID: 11092698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of both Th1 and Th2 cytokines correlates with the histological rejection of MHC-matched and MHC-mismatched foetal pancreas allografts in mice.
    Kovarik J; Koulmanda M; Mandel TE
    Immunol Cell Biol; 1997 Jun; 75(3):303-9. PubMed ID: 9243297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
    Faust A; Rothe H; Schade U; Lampeter E; Kolb H
    Transplantation; 1996 Sep; 62(5):648-52. PubMed ID: 8830831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of V beta 8 cells in disease recurrence in isografts in diabetic NOD mice.
    Bacelj A; Charlton B; Koulmanda M; Mandel TE
    Transplant Proc; 1990 Oct; 22(5):2167-8. PubMed ID: 2219331
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of lipid antigen presentation, cytokine balance, and major histocompatibility complex in a novel murine model of adoptive transfer of insulitis.
    Ylinen L; Teros T; Liukas A; Arvilommi P; Sainio-Pöllänen S; Veräjänkorva E; Pöllänen P; Simell O
    Pancreas; 2000 Mar; 20(2):197-205. PubMed ID: 10707937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
    Rothe H; O'Hara RM; Martin S; Kolb H
    Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cotransplanted fetal liver on fetal pancreas isografts.
    Wang XG; Tafra L; Berezniak R; Lloyd RV; Muraika L; Dafoe DC
    Transplantation; 1992 Feb; 53(2):272-6. PubMed ID: 1738919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
    Leijon K; Hillörn V; Bergqvist I; Holmberg D
    J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice.
    Mandel TE; Kovarik J; Koulmanda M
    Am J Pathol; 1995 Sep; 147(3):834-44. PubMed ID: 7677195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.